ORTHOCELL LIMITED — Director's Dealing 2024

Jan 15, 2024

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity	ORTHOCELL LIMITED
ABN	57 118 897 135

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	MR MATTHEW CALLAHAN
Date of last notice	29 January 2021
Date that director ceased to be director	15 January 2024

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Nil

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances giving rise tothe relevant interestSRV Nominees Pty LtdShenasaby Investments Pty Ltd<For the Shenasaby A/C>< Shenasaby Investment P/L A/C>< Shenasaby Trust>< Shenasaby Family Trust><Shenasaby Super Fund A/C>(Mr Callahan is a beneficiary of the trusts)	Number & class of securitiesCircumstances200,000 Ordinary Shares21,053 Ordinary Shares47,000 Ordinary Shares371,710 Ordinary Shares577,359 Ordinary Shares2,000,000 Unlisted Options exercisable @ $0.583expiring 14 October 202512,500 Ordinary Shares

Part 3 – Director’s interests in contracts

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
No. and class of securities to whichinterest relates	N/A

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002